MyAverix Finance
F · Healthcare
EVEREST MED.LTD DL-0001 (6HN)
Biotechnology
EVEREST MED.LTD DL-0001 (6HN) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6HN
EVEREST MED.LTD DL-0001 (6HN) — FAQ
What is 6HN's P/E ratio?
The price-to-earnings (P/E) ratio for EVEREST MED.LTD DL-0001 (6HN) is 25.00 (data as of 2026-05-23).
Does EVEREST MED.LTD DL-0001 pay a dividend?
Dividend yield is not available in the current snapshot for EVEREST MED.LTD DL-0001 (6HN). Check the MyAverix Finance app for the latest dividend data.
What sector is EVEREST MED.LTD DL-0001 in?
EVEREST MED.LTD DL-0001 (6HN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 6HN listed on?
6HN is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.